FutureGen
About:
FutureGen is a research and development manufacturer for antibody medication.
Website: http://www.futuregen.com.cn
Top Investors: Lilly Asia Ventures, Sinopharm Capital, MSA Capital, Dyee Capital, Zhongjin Qide
Description:
FutureGen is a biopharmaceutical company that develops innovative biologics. The company works in the fields of immunology and cancer, concentrating on the creation and commercialization of novel biologics. The STEP (Structure-based Targeted Evolution Platform) from FutureGen is a cutting-edge screening platform designed specifically for protein drug screening. It integrates several technologies to quickly screen and produce the best antibodies. FutureGen has experience in medication development, clinical research, CMC, and quality in the business world.
300M CNY
Changping, Beijing, China
2014-01-01
hr(AT)futuregenbiopharm.com
Jin Zhaoyu
51-100
2021-03-12
Private
© 2025 bioDAO.ai